Company Review. At a reasonable time prior to the filing, issuance, or other submission or public disclosure of any statement, filing, notice, application, press release or other document made by or on behalf of the Parent Parties to any Governmental Authority or other third party in connection with the transactions contemplated by this Agreement, including the Proxy Statement/Prospectus, and amendment or supplement thereto and any other filing with the SEC, or the submission of responses to comments from the SEC or its staff in connection therewith, the Company and its counsel shall be given a reasonable opportunity to review and comment upon such document or response and give its written consent to the form thereof prior to filing, issuance, submission or disclosure thereof. Furthermore, the Parent Parties shall consider the comments of the Company or its counsel in good faith and cooperate and mutually agree upon any response to any SEC comments on any such document. The Parent Parties shall provide the Company and its counsel with a reasonable opportunity to participate in the response of Parent to any written or oral comments received from the SEC or its staff.
Company Review. No material about Company shall be distributed by Publisher unless and until Company has reviewed and approved same. Company will act diligently and promptly in reviewing materials submitted to it by Publisher to enhance timely distribution of the materials and will inform Publisher, in writing, of any inaccuracies contained in the material prepared prior to the projected publication and/or delivery dates. Company will acknowledge in writing that the material is acceptable (as corrected, if applicable).
Company Review. No material about the Company shall be distributed by Capital unless and until the Company has reviewed all information relating to the Company in the email package. The Company will act diligently and promptly in reviewing the information in the email package submitted to it by Capital to enhance timely distribution of the materials and will inform Capital in writing of any inaccuracies contained in the material prepared prior to the projected publication and/or delivery dates. The Company will represent and warrant in writing that all information, including financial information which Company provides Capital is correct in all aspects and is not false or misleading in any material respect.
Company Review. No material about the Company shall be distributed by Publisher unless and until the Company has reviewed and approved the same. The Company will act diligently and promptly in reviewing materials submitted to it by Publisher to enhance timely distribution of the materials and will inform Publisher of any inaccuracies contained at least fifteen (15) business days prior to the projected publication and/or delivery date. However, if Publisher has failed to deliver such material to the Company at least twenty (20) business days prior to such projected date, such date shall be extended from day to day to allow the Company to respond prior to such fifteen (15) business days.
Company Review. Buyer:
(i) Has such Knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of its investment in the Shares contemplated hereby, and that Buyer is able to bear the economic risk of such investment indefinitely.
(ii) Has (A) had the opportunity to meet with officers and other representatives of the Company to discuss its business, assets, liabilities, financial condition, cash flow, and operations, and (B) received all materials, documents and other information that it deems necessary or advisable to evaluate an investment in the Shares and the Transactions.
(iii) Has made its own independent examination, investigation, analysis and evaluation of the Shares, including its own estimate of the value of the Shares.
(iv) Has undertaken such due diligence (including a review of the assets, properties, liabilities, books, records, and Contracts of the Company and the Company Subsidiaries) as it deems adequate, including that described above. Nothing in this Section 3.3(d) will preclude Buyer from relying on the representations, warranties, covenants, and agreements of Seller herein or from pursuing its remedies with respect to a Breach thereof except as limited by Section 9.6 hereof.
Company Review. No material about the Company shall be distributed by Capital unless and until the Company has reviewed all information relating to the Company in the mail package. The Company will act diligently and promptly in reviewing the information in the Direct Mail Package submitted to it by Capital to enhance timely distribution of the materials and will inform Capital in writing of any inaccuracies contained in the material prepared prior to the projected publication and/or delivery dates. The Company will represent and warrant in writing that all information, including financial information which Company provides Capital is correct in all aspects and is not false or misleading in any material respect.
Company Review. The Seller shall have completed and be reasonably satisfied with its confidential and nondisclosed review of the business, management, finances, and supplier and customer relations of the Buyer.
Company Review. Illinois and its researchers will have the right to publish or otherwise disclose the results of Research Project. Illinois, through the Principal Investigator, will furnish Company a copy of any proposed manuscript or presentation materials which incorporates information or results from the Research Project at least thirty (30) days prior to any submission for publication or public disclosure.
Company Review. The Purchaser:
(i) has such experience in financial and business matters that it is capable of evaluating the merits and risks of its investment in the Big Bend Equity Interests and Contran Insurance Equity Interests contemplated hereby, and that the Purchaser is able to bear the economic risk of such investment indefinitely.
(ii) has (A) had the opportunity to meet with representative officers and other representatives of each Company to discuss its business, assets, liabilities, financial condition, cash flow, and operations, and (B) received all materials, documents and other information that it deems necessary or advisable to evaluate the Big Bend Equity Interests and Contran Insurance Equity Interests and the transactions contemplated hereby.
(iii) has made its own independent examination, investigation, analysis and evaluation of the Big Bend Equity Interests and Contran Insurance Equity Interests, including its own estimate of their value.
(iv) has undertaken such due diligence (including a review of the Companies' assets, properties, liabilities, books, records and contracts) as it deems adequate, including that described above. Nothing in this Section 6(e) will preclude the Purchaser from relying on the representations, warranties, covenants, and agreements of the Sellers herein or from pursuing their remedies with respect to a breach thereof.
Company Review. The Company acknowledges that:
(a) it has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of the purchase of the Parent Common Stock contemplated by this Agreement;
(b) (i) it has had the opportunity to visit with the representative officers and other representatives of Parent to discuss the business and assets, liabilities, financial condition, cash flow and operations of Parent, and (ii) it has received all materials, documents and other information that it deems necessary or advisable to evaluate the Merger Consideration and the Transactions;
(c) it has made its own independent examination, investigation, analysis and evaluation of Parent, including the Company's own estimate of the value of the Merger Consideration; and
(d) it has undertaken such due diligence (including a review of the assets, properties, liabilities, books, records and contracts of Parent) as the Company deems adequate, including that described above.
(e) Nothing in Sections 2.29(a) through 2.29(d) shall preclude the Company from relying on the representations, warranties, covenants and agreements herein or from pursuing its remedies with respect to a breach thereof.
